Brief: Armata Pharma Enters Into New Lease To Build Research And Development And GMP Manufacturing Facility In Los Angeles
02/11/2021 21:35
Nov 2 (Reuters) - Armata Pharmaceuticals Inc ARMP.A :
* ARMATA PHARMACEUTICALS - ENTERED INTO NEW LEASE TO BUILD A
56,300 SQUARE-FOOT RESEARCH AND DEVELOPMENT AND GMP
MANUFACTURING FACILITY IN LOS ANGELES
Source text: (https://bit.ly/2ZRdmHS)
Further company coverage: ARMP.A
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Armata Pharmaceuticals
See all newsBrief: Armata Pharmaceuticals Announces First Quarter 2026 Results And Provides Corporate Update
Brief: Armata Pharmaceuticals Delays Announcement Of Fourth Quarter And Full-Year 2025 Results And Provides Corporate Update
Brief: Armata Pharmaceuticals Receives FDA Qualified Infectious Disease Product Designation
Armata Pharma jumps on US FDA nod for late-stage infection trial
Brief: Armata Pharmaceuticals Commissions cGMP Manufacturing Facility In Los Angeles